The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. (2017)

First Author: Imamura K
Attributed to:  MRC Centre for Regenerative Medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aaf3962

PubMed Identifier: 28539470

Publication URI: http://europepmc.org/abstract/MED/28539470

Type: Journal Article/Review

Volume: 9

Parent Publication: Science translational medicine

Issue: 391

ISSN: 1946-6234